Cargando…
Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer’s Disease
Autores principales: | Hüll, Michael, Sadowsky, Carl, Arai, Heii, Leterme, Ghislaine Le Prince, Holstein, Ann, Booth, Kevin, Peng, Yahong, Yoshiyama, Tamotsu, Suzuki, Hideo, Ketter, Nzeera, Liu, Enchi, Ryan, J. Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543567/ https://www.ncbi.nlm.nih.gov/pubmed/28124589 http://dx.doi.org/10.2174/1567205014666170117101537 |
Ejemplares similares
-
Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis
por: Arrighi, H Michael, et al.
Publicado: (2016) -
Test Of Closure Of Orbit BumPS In Qs3, Qs4, Qs5, Qs6
por: Koutchouk, Jean-Pierre, et al.
Publicado: (1991) -
QS5: The Effect of Stem Cells and Local Tacrolimus on Neurite Extension
por: Saffari, Sara, et al.
Publicado: (2021) -
Medical resource utilization among patients with ventilator-associated pneumonia: pooled analysis of randomized studies of doripenem versus comparators
por: Kollef, Marin H, et al.
Publicado: (2010) -
The AccTesting Framework: An Extensible Framework for Accelerator Commissioning and Systematic Testing
por: Gorzawski, A A, et al.
Publicado: (2014)